FDA approves drug from Bayer, Onyx to fight liver cancer

11/19/2007 | Yahoo! · American City Business Journals

Onyx Pharmaceuticals and partner Bayer Healthcare Pharmaceuticals obtained U.S. approval to market the kidney drug Nexavar for the treatment of unresectable hepatocellular carcinoma, a form of liver cancer. The decision makes the drug the first systemic therapy for liver cancer to obtain regulatory approval.

View Full Article in:

Yahoo! · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC